WASHINGTON (AP) \u2014 Rep. Tom Marino, President Donald Trump\u2019s nominee to be the nation\u2019s drug czar, has withdrawn from consideration following reports that he played a key role in weakening the federal government\u2019s authority to stop companies from distributing opioids.<\/p>\n\n\n\n
\u201cHe didn\u2019t want to have even the perception of a conflict of interest with drug companies or, frankly, insurance companies,\u201d Trump told Fox News Radio in an interview Tuesday, shortly after breaking the news on Twitter.<\/p>\n\n\n\n
The announcement follows reports by The Washington Post and CBS News, which detailed the Pennsylvania lawmaker\u2019s involvement in crafting a 2016 law, signed by President Barack Obama, that weakened the Drug Enforcement Administration\u2019s authority to curb opioid distribution.<\/p>\n\n\n\n
It also comes amid growing pressure on Trump to fulfill his pledge to declare the nation\u2019s opioid epidemic a \u201cnational emergency,\u201d as a commission he\u2019s convened on the subject has urged him to do. Trump said Monday that he would be making \u201ca major announcement\u201d on the topic next week.<\/p>\n\n\n\n
Interviewed by Fox News Radio\u2019s Brian Kilmeade, Trump said Marino \u201cfelt compelled\u201d to step down from the job.<\/p>\n\n\n\n
\u201cHe feels very strongly about the opioid problem and the drug problem and Tom Marino said, \u2018Look, I\u2019ll take a pass,\u2019\u201d Trump added. Trump did not say when he and the congressman spoke. Marino could not immediately be reached Tuesday for comment.<\/p>\n\n\n\n
Trump had announced the news in an early-morning tweet, telling his supporters that Marino had \u201cinformed me that he is withdrawing his name from consideration as drug czar.\u201d<\/p>\n\n\n\n
\u201cTom is a fine man and a great Congressman!\u201d he added.<\/p>\n\n\n\n
Trump had told reporters during a news conference in the White House Rose Garden on Monday that he would look \u201cvery closely\u201d at the reports about Marino, adding: \u201cIf I think it\u2019s 1 percent negative to doing what we want to do, I will make a change,\u201d he said.<\/p>\n\n\n\n
Democrats had called on Trump to withdraw the nomination, and hailed the news, with Senate Minority Leader Chuck Schumer calling Marino\u2019s decision the \u201cright decision.\u201d<\/p>\n\n\n\n
\u201cWe need a drug czar who has seen these devastating effects and who is passionate about ending this opioid epidemic,\u201d said Democratic Sen. Joe Manchin, whose home state of West Virginia has been among the hardest-hit by the opioid epidemic.<\/p>\n\n\n\n
Manchin had scolded the Obama administration for failing to \u201csound the alarm on how harmful that bill would be for our efforts to effectively fight the opioid epidemic,\u201d which kills an estimated 142 people a day nationwide.<\/p>\n\n\n\n
In a letter to Trump, Manchin called the opioid crisis \u201cthe biggest public health crisis since HIV\/AIDS,\u201d and said, \u201cwe need someone leading the White House Office of National Drug Control Policy who believes we must protect our people, not the pharmaceutical industry.\u201d<\/p>\n\n\n\n
The Post reported Sunday that the drug industry worked behind the scenes with lobbyists and key members of Congress, including Marino, pouring more than a million dollars into their election campaigns. The major drug distributors prevailed upon the Drug Enforcement Administration and the Justice Department to agree to the industry-friendly law, which undermined efforts to restrict the flow of pain pills that have led to tens of thousands of deaths.<\/p>\n\n\n\n
Sen. Orrin Hatch, R-Utah, the bill\u2019s lead Senate sponsor, defended the measure Monday, calling allegations that he or Marino \u201cconspired\u201d with drug companies \u201cutterly ridiculous.\u201d Hatch, a 40-year veteran of the Senate, said he was \u201cno patsy\u201d of the drug industry.<\/p>\n\n\n\n
The language affecting DEA enforcement authority was suggested by DEA and the Justice Department, Hatch said, adding that the agencies could have tried to stop the bill at any time \u2014 or recommended that Obama veto the measure.<\/p>\n\n\n\n
\u201cLet\u2019s not pretend that DEA, both houses of Congress and the Obama White House all somehow wilted under Representative Marino\u2019s nefarious influences,\u201d Hatch said.<\/p>\n\n\n\n
Sen. Claire McCaskill, D-Mo., said Monday she will introduce legislation to repeal the 2016 law.<\/p>\n\n\n\n
A White House commission convened by Trump and led by New Jersey Gov. Chris Christie has called on Trump to declare a national emergency to help deal with the growing opioid crisis. An initial report from the commission in July noted that the approximate 142 deaths each day from drug overdoses mean the death toll is \u201cequal to September 11th every three weeks.\u201d<\/p>\n\n\n\n
Deputy Attorney General Rod Rosenstein also announced Tuesday that a pair of Chinese nationals had been indicted on charges that they manufactured tons of fentanyl and other powerful narcotics that were then peddled in the United States. Rosenstein said the pair ran one of the world\u2019s most prolific drug trafficking and money laundering organizations. Also indicted were more than a dozen people accused of trafficking the drugs in the U.S. and Canada.<\/p>\n\n\n\n
Rep. Tom Marino, President Donald Trump\u2019s nominee to be the nation\u2019s drug czar, has withdrawn from consideration following reports that he played a key role in weakening the federal government\u2019s authority to stop companies from distributing opioids.<\/p>\n","protected":false},"author":7,"featured_media":38207,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","_yoast_wpseo_canonical":"","_acf":"","_yoast_wpseo_primary_category":68,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","_smg_distribution_targets":[]},"categories":[106,31,15,68,33],"tags":[],"coauthors":[2638,2924],"class_list":["post-13523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily-brief","category-home","category-management","category-leadership","category-newsletters"],"acf":{"subheadline":"","legacy_arc_id":"TZX266PXBVFLXBHXONDE5TQACM","arc_canonical_url":"\/management\/leadership\/2017\/10\/17\/trump-drug-czar-nominee-pulls-his-name-from-consideration\/","remove_feature_photo":false,"is_sponsored":false,"subtype":"","redirect_url":"","disable_inline_ads":false,"native_logo_pretext":"Presented By:"},"yoast_head":"\n